Skip to main content

Diagnostic options Β· UAE

Biochemistry tests in Dubai & UAE

Compare available Biochemistry tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

1,113

Listed price range

450.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Biochemistry test prices

Showing 1036–1050 of 1,113 matching tests.

Biochemistry diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-3337
Trimipramine Therapeutic Drug Monitoring Test

This diagnostic test evaluates the concentration of trimipramine in the patient's serum to guide safe and effective dosing.

Serum 2–3 weeks 1,800.00 AED
View
View test specifications and preparation
What it measures
["Serum Trimipramine Concentration"]
Parameters
[{"name": "Trimipramine", "reference_range": "0.1 ng/mL (LOD)"}]
Preparation
["Hold morning dose", "Take medication after blood draw", "Resume normal schedule unless instructed otherwise"]
Indications
["Monitoring therapeutic levels", "Assessing adherence", "Guiding dose adjustments", "Investigating suspected toxicity"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 3949-0 ICD-10: Z51.81
Clinical summary
This diagnostic test evaluates the concentration of trimipramine in the patient's serum to guide safe and effective dosing.
TEST-6122
TRPM6 Gene Hypomagnesemia Type 1 Genetic Test

This genetic test evaluates the TRPM6 gene for mutations associated with hereditary hypomagnesemia type 1.

Peripheral whole blood (EDTA tube) 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TRPM6 gene"]
Parameters
[]
Preparation
[]
Indications
["Suspected primary familial hypomagnesemia with secondary hypocalcemia", "Family screening for at-risk relatives"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 93257-0 ICD-10: E83.42
Clinical summary
This genetic test evaluates the TRPM6 gene for mutations associated with hereditary hypomagnesemia type 1.
TEST-2492
TRPV3 Gene Olmsted Syndrome Genetic Test

This diagnostic test evaluates the TRPV3 gene for pathogenic mutations associated with Olmsted syndrome.

Peripheral Whole Blood / Extracted DNA / FTA Card 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic mutations in the TRPV3 gene", "Single nucleotide variants", "Small insertions", "Small deletions"]
Parameters
[]
Preparation
["Mandatory pre-test genetic counselling", "Mandatory pedigree chart completion"]
Indications
["Suspected Olmsted syndrome", "Genetic counseling for affected families", "Family cascade screening"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 50398-7 ICD-10: Q82.8
Clinical summary
This diagnostic test evaluates the TRPV3 gene for pathogenic mutations associated with Olmsted syndrome.
TEST-4071
TRPV4 Gene CMT2C Next-Generation Sequencing (Genetic Test

This genetic test evaluates the TRPV4 gene for pathogenic variants associated with Charcot‑Marie‑Tooth disease type 2C.

Whole Blood (Peripheral Venous Blood) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TRPV4 gene", "Single-nucleotide variants", "Indels", "Copy-number changes"]
Parameters
[]
Preparation
["No fasting required", "Must attend a genetic counselling session beforehand"]
Indications
["Suspected Charcot‑Marie‑Tooth disease type 2C", "Confirmation of molecular diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81306-1 ICD-10: G60.0
Clinical summary
This genetic test evaluates the TRPV4 gene for pathogenic variants associated with Charcot‑Marie‑Tooth disease type 2C.
TEST-3319
Trypsin Test

This diagnostic test evaluates pancreatic exocrine function by measuring serum trypsin levels.

Serum (peripheral whole blood) 2-3 weeks after sample collection by 7th of month 1,500.00 AED
View
View test specifications and preparation
What it measures
["Serum trypsin levels", "Pancreatic exocrine function"]
Parameters
[{"name": "Trypsin", "reference_range": null}]
Preparation
["Fasting for 8-12 hours is recommended", "Disclose recent isotope therapy"]
Indications
["Diagnosis of chronic pancreatitis", "Diagnosis of cystic fibrosis", "Evaluation of pancreatic insufficiency"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 2698-9 ICD-10: K86.1, K85.9
Clinical summary
This diagnostic test evaluates pancreatic exocrine function by measuring serum trypsin levels.
TEST-3324
Tryptophan Quantitative Plasma Test

This diagnostic test evaluates the concentration of the essential amino acid tryptophan in plasma, aiding in the identification of metabolic disorders.

Plasma 2–3 weeks (batch processing) 2,500.00 AED
View
View test specifications and preparation
What it measures
["Plasma Tryptophan Level", "Amino Acid Metabolism"]
Parameters
[{"name": "Tryptophan", "reference_range": "Reported in Β΅mol/L with age-specific reference ranges"}]
Preparation
["Overnight fasting or β‰₯4 hours post-meal", "Non-fasting pediatric samples acceptable", "Complete and sign Send Out Consent Form (Form 35)", "Inform phlebotomist of medications/supplements containing tryptophan"]
Indications
["Screening for inborn errors of metabolism", "Diagnosis of Hartnup disease", "Diagnosis of tryptophanuria", "Evaluation of aromatic amino acid disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 14556-2 ICD-10: E72.0, Z13.228
Clinical summary
This diagnostic test evaluates the concentration of the essential amino acid tryptophan in plasma, aiding in the identification of metabolic disorders.
TEST-5834
TSC1 Gene Tuberous Sclerosis Genetic Test

This test sequences the entire TSC1 gene to detect pathogenic variants associated with Tuberous Sclerosis Complex (TSC). It identifies the genetic cause of the disorder in affected...

Whole Blood (3–5 mL in EDTA), Extracted DNA, or Buccal Swab / FTA Card 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TSC1 gene", "Full gene coverage including exons and splice sites"]
Parameters
[]
Preparation
["No fasting required", "Inform phlebotomist if taking anticoagulants"]
Indications
["Confirming a genetic diagnosis of Tuberous Sclerosis Complex", "Guiding lifelong surveillance and management", "Genetic counselling for affected families"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82991-3 ICD-10: Q85.1
Clinical summary
This test sequences the entire TSC1 gene to detect pathogenic variants associated with Tuberous Sclerosis Complex (TSC). It identifies the genetic cause of the disorder in affected individuals.
TEST-5929
TSC2 Gene (Tuberous Sclerosis Type 2) Genetic Test

This test evaluates the TSC2 gene for pathogenic variants associated with Tuberous Sclerosis Complex type 2.

Peripheral whole blood (EDTA) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in TSC2 gene", "Point mutations", "Small indels", "Copy number variations"]
Parameters
[]
Preparation
["Inform genetic counselor about anticoagulant therapy before sample collection"]
Indications
["Suspected diagnosis of Tuberous Sclerosis Complex type 2", "Family history of TSC2-related disorders", "Genetic counseling for at-risk individuals"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 57937-2 ICD-10: Q85.1
Clinical summary
This test evaluates the TSC2 gene for pathogenic variants associated with Tuberous Sclerosis Complex type 2.
TEST-3699
TSHB Gene Sequencing for Congenital Nongoitrous Hypothyroidism Type 4 (Genetic Test)

This test identifies genetic mutations in the TSHB gene responsible for congenital nongoitrous hypothyroidism type 4.

Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot on FTA Card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TSHB gene", "Single-nucleotide variants", "Small insertions/deletions", "Copy-number alterations"]
Parameters
[]
Preparation
["Patients must not discontinue levothyroxine or any thyroid hormone replacement therapy before, during, or after genetic sampling."]
Indications
["Confirmed diagnosis of congenital nongoitrous hypothyroidism type 4", "Neonates with abnormal newborn TSH screening but no palpable goitre", "Children with developmental delay and low TSH", "Families with a history of congenital hypothyroidism of unknown genetic origin"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 53494-5 ICD-10: E03.1
Clinical summary
This test identifies genetic mutations in the TSHB gene responsible for congenital nongoitrous hypothyroidism type 4.
TEST-4104
TSPYL1 Gene Sudden Infant Death with Dysgenesis of the Testes Syndrome Genetic Test

This test identifies pathogenic variants in the TSPYL1 gene associated with Sudden Infant Death with Dysgenesis of the Testes Syndrome (SIDDT).

Peripheral whole blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TSPYL1 gene", "Copy Number Variations (CNV) in the TSPYL1 gene"]
Parameters
[]
Preparation
["Pre-test genetic counseling session required", "Do not discontinue prescribed medications"]
Indications
["Unexplained infant death", "Infant death with testicular dysgenesis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 29577-1 ICD-10: R95.0, Q55.1
Clinical summary
This test identifies pathogenic variants in the TSPYL1 gene associated with Sudden Infant Death with Dysgenesis of the Testes Syndrome (SIDDT).
TEST-2876
TSR2 Gene Sequencing for Diamond-Blackfan Anemia Type 14 with Mandibulofacial Dysostosis Test

This diagnostic test evaluates the TSR2 gene for pathogenic variants associated with Diamond-Blackfan anemia type 14 and mandibulofacial dysostosis.

Peripheral blood (5–10 mL) in EDTA tube or extracted DNA 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TSR2 gene"]
Parameters
[]
Preparation
["No specific fasting required", "No medication modification needed unless instructed by physician"]
Indications
["Suspected Diamond-Blackfan anemia type 14", "Suspected mandibulofacial dysostosis", "Genetic counseling for families with affected individuals"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: D61.01, Q75.4
Clinical summary
This diagnostic test evaluates the TSR2 gene for pathogenic variants associated with Diamond-Blackfan anemia type 14 and mandibulofacial dysostosis.
TEST-4528
TTC37 Gene Trichohepatoenteric Syndrome Type 1 Genetic Test

This test identifies pathogenic variants in the TTC37 gene associated with Trichohepatoenteric syndrome type 1 (THES1).

Peripheral whole blood (3–5 mL in EDTA tube) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TTC37 gene", "Full coding region and splice sites of the TTC37 gene"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of recent blood transfusions"]
Indications
["Suspected diagnosis of Trichohepatoenteric syndrome type 1 (THES1)", "Family history of THES1", "Need for precise clinical management and family planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81373-8 ICD-10: Q87.8
Clinical summary
This test identifies pathogenic variants in the TTC37 gene associated with Trichohepatoenteric syndrome type 1 (THES1).
TEST-4977
TTI2 Gene Sequencing (MRT39) Test

This test evaluates the TTI2 gene for pathogenic variants associated with autosomal recessive intellectual disability type 39 (MRT39). It detects single nucleotide variants, small...

Peripheral whole blood (EDTA tube) or buccal swab / saliva (paediatric cases) 3 to 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["TTI2 gene coding region", "TTI2 gene intron-exon boundaries", "Copy Number Variations (CNVs) in TTI2 gene"]
Parameters
[]
Preparation
["No specific fasting required", "No specific medication or diet restrictions"]
Indications
["Suspected intellectual disability type 39 (MRT39)", "Developmental delay with features suggestive of MRT39"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94218-1 ICD-10: F78
Clinical summary
This test evaluates the TTI2 gene for pathogenic variants associated with autosomal recessive intellectual disability type 39 (MRT39). It detects single nucleotide variants, small insertions/deletions, and copy number variations (CNVs) using Next-Generation Sequencing.
TEST-4827
TTN Gene Limb‑Girdle Muscular Dystrophy, Autosomal Recessive Type 2J Genetic Test

This test identifies pathogenic variants in the TTN gene associated with Limb-Girdle Muscular Dystrophy Type 2J (LGMD2J).

Whole Blood (EDTA) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TTN gene", "Molecular diagnosis of LGMD2J"]
Parameters
[]
Preparation
["No specific fasting required", "Maintain current medication regimen unless advised otherwise by a specialist"]
Indications
["Suspected diagnosis of LGMD2J", "Genetic counseling for affected families", "Differential diagnosis of muscular dystrophies"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81308-4 ICD-10: G71.0, Z13.79, Z14.8
Clinical summary
This test identifies pathogenic variants in the TTN gene associated with Limb-Girdle Muscular Dystrophy Type 2J (LGMD2J).
TEST-5944
TTPA Gene (Familial Vitamin E Deficiency) Genetic Test

This genetic test identifies mutations in the TTPA gene responsible for causing Ataxia with Vitamin E Deficiency (AVED). It provides a definitive molecular diagnosis for patients w...

Peripheral whole blood, venous blood, or FTA blood spot (DNA) 3 to 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic mutations in the TTPA gene", "Coding region and intron-exon boundaries of the TTPA gene"]
Parameters
[]
Preparation
["No specific fasting required", "Continue all prescribed medications unless advised otherwise by your physician"]
Indications
["Suspected Ataxia with Vitamin E Deficiency (AVED)", "Family history of AVED", "Unexplained ataxia with low vitamin E levels"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 95819-7 ICD-10: E56.0, G11.0
Clinical summary
This genetic test identifies mutations in the TTPA gene responsible for causing Ataxia with Vitamin E Deficiency (AVED). It provides a definitive molecular diagnosis for patients with progressive neurological symptoms.

Category overview

Biochemistry: overview

Seeking clarity about your body's essential functions is vital for long-term well-being. At DNA Labs UAE, our Biochemistry services utilize advanced automated analyzers to evaluate enzymes, proteins, and metabolites in your blood. Whether you need routine metabolic panels or specialized biochemical testing in the UAE, these tests provide critical data to guide your physician's medical plan. As a leading diagnostic lab in Dubai and the UAE, we guarantee strict confidentiality and rapid, accurate turnaround times. Take charge of your health today. Explore our biochemistry diagnostics below, schedule a convenient home sample collection, or contact our specialists to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area